ADAPTeR Study: scRNA and scTCR data from TILs from two ccRCC patients treated with anti-PD1

ABSTRACT: TILs were extracted from two ccRCC patients treated with (Nivolumab) anti-PD1, one was responsive to treatment, the other non-responsive. IgG4 staining was used to separate cells into anti-PD1 bound and unbound, the samples then underwent paired scRNA and scTCR sequencing on the 10x Genomics platform.

PROVIDER: EGAS00001005640 | EGA |

REPOSITORIES: EGA